American Journal of Respiratory Cell and Molecular Biology. Vol. 27, pp. 419-427, 2002
© 2002 American Thoracic Society DOI: 10.1165/rcmb.2002-0009OC
Interaction of IL-13 and C10 in the Pathogenesis of Bleomycin-Induced Pulmonary Fibrosis
John A. Belperio,
Maria Dy,
Marie D. Burdick,
Ying Y. Xue,
Kewang Li,
Jack A. Elias and
Michael P. Keane
Department of Medicine, Division of Pulmonary and Critical Care Medicine, UCLA School of Medicine, Los Angeles, California; and Division of Pulmonary and Critical Care Medicine, Yale University, New Haven, Connecticut
Address correspondence to: Dr. Michael P. Keane, UCLA, Department of Medicine, Division of Pulmonary and Critical Care Medicine, 900 Veteran Ave, 14-154 Warren Hall, Los Angeles, CA 90095-1922. E-mail: mpkeane{at}mednet.ucla.edu
The initial stimulus for inflammatory cell recruitment and the mechanisms responsible for the perpetuation and evolution of chronic inflammation, granulation tissue formation, and fibrosis have not been fully elucidated. Although interleukin (IL)-13, a Th2 cytokine, has been shown to have direct effects on fibroblasts that support fibroproliferation, it is also a potent inducer of a novel CC chemokine, C10, which is chemotactic for mononuclear phagocytes. The macrophage/mononuclear phagocyte has been shown to have a role in the pathogenesis of pulmonary fibrosis, serving as an important source of growth factors that regulate extracellular matrix synthesis. In this study we demonstrate that IL-13 and C10 are elevated in the pathogenesis of bleomycin-induced pulmonary fibrosis. Neutralization of IL-13, but not IL-4, attenuated bleomycin-induced pulmonary fibrosis and levels of C10, suggesting that IL-13 has an important role in the development of pulmonary fibrosis. IL-13 is a potent inducer of C10 in vivo, and neutralization of C10 attenuated bleomycin-induced pulmonary fibrosis and intrapulmonary macrophage numbers. This suggests that IL-13 has a role in the development of pulmonary fibrosis that is independent of its direct effect on fibroblasts and is evidence for an interaction between Th2 cytokines and specific CC chemokines.
Abbreviations: bronchoalveolar lavage, BAL BAL fluid, BALF enzyme-linked immunosorbent assay, ELISA interferon- , IFN- interleukin, IL idiopathic pulmonary fibrosis, IPF macrophage inflammatory protein, MIP matrix metalloproteinase, MMP phosphate-buffered saline, PBS polymerase chain reaction, PCR transforming growth factor, TGF tissue inhibitor of metalloproteinase, TIMP tumor necrosis factor, TNF
This article has been cited by other articles:

|
 |

|
 |
 
T J Williams and J W Wilson
Challenges in pulmonary fibrosis: 7 {middle dot} Novel therapies and lung transplantation
Thorax,
March 1, 2008;
63(3):
277 - 284.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Zheng, W. Liu, S.-Y. Oh, Z. Zhu, B. Hu, R. J. Homer, L. Cohn, M. J. Grusby, and J. A. Elias
IL-13 Receptor {alpha}2 Selectively Inhibits IL-13-Induced Responses in the Murine Lung
J. Immunol.,
January 1, 2008;
180(1):
522 - 529.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. P. Chapoval, A. Al-Garawi, J. M. Lora, I. Strickland, B. Ma, P. J. Lee, R. J. Homer, S. Ghosh, A. J. Coyle, and J. A. Elias
Inhibition of NF-{kappa}B Activation Reduces the Tissue Effects of Transgenic IL-13
J. Immunol.,
November 15, 2007;
179(10):
7030 - 7041.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. L. Coelho, M. A. Schaller, C. F. Benjamim, A. Z. Orlofsky, C. M. Hogaboam, and S. L. Kunkel
The Chemokine CCL6 Promotes Innate Immunity via Immune Cell Activation and Recruitment
J. Immunol.,
October 15, 2007;
179(8):
5474 - 5482.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. M. Pierce, K. Carpenter, C. Jakubzick, S. L. Kunkel, K. R. Flaherty, F. J. Martinez, and C. M. Hogaboam
Therapeutic Targeting of CC Ligand 21 or CC Chemokine Receptor 7 Abrogates Pulmonary Fibrosis Induced by the Adoptive Transfer of Human Pulmonary Fibroblasts to Immunodeficient Mice
Am. J. Pathol.,
April 1, 2007;
170(4):
1152 - 1164.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. P. Keane, B. N. Gomperts, S. Weigt, Y. Y. Xue, M. D. Burdick, H. Nakamura, D. A. Zisman, A. Ardehali, R. Saggar, J. P. Lynch III, et al.
IL-13 Is Pivotal in the Fibro-Obliterative Process of Bronchiolitis Obliterans Syndrome
J. Immunol.,
January 1, 2007;
178(1):
511 - 519.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Misson, F. Brombacher, M. Delos, D. Lison, and F. Huaux
Type 2 immune response associated with silicosis is not instrumental in the development of the disease
Am J Physiol Lung Cell Mol Physiol,
January 1, 2007;
292(1):
L107 - L113.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. M. Shim, Z. Zhu, T. Zheng, C. G. Lee, R. J. Homer, B. Ma, and J. A. Elias
Role of 5-Lipoxygenase in IL-13-Induced Pulmonary Inflammation and Remodeling
J. Immunol.,
August 1, 2006;
177(3):
1918 - 1924.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. G. Lee, H.-R. Kang, R. J. Homer, G. Chupp, and J. A. Elias
Transgenic Modeling of Transforming Growth Factor-{beta}1: Role of Apoptosis in Fibrosis and Alveolar Remodeling.
Proceedings of the ATS,
July 1, 2006;
3(5):
418 - 423.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. N. Lama, H. Harada, L. N. Badri, A. Flint, C. M. Hogaboam, A. McKenzie, F. J. Martinez, G. B. Toews, B. B. Moore, and D. J. Pinsky
Obligatory Role for Interleukin-13 in Obstructive Lesion Development in Airway Allografts
Am. J. Pathol.,
July 1, 2006;
169(1):
47 - 60.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Ma, W. Liu, R. J. Homer, P. J. Lee, A. J. Coyle, J. M. Lora, C. G. Lee, and J. A. Elias
Role of CCR5 in the Pathogenesis of IL-13-Induced Inflammation and Remodeling.
J. Immunol.,
April 15, 2006;
176(8):
4968 - 4978.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. J. Cho, M. J. Kang, R. J. Homer, H. R. Kang, X. Zhang, P. J. Lee, J. A. Elias, and C. G. Lee
Role of Early Growth Response-1 (Egr-1) in Interleukin-13-induced Inflammation and Remodeling
J. Biol. Chem.,
March 24, 2006;
281(12):
8161 - 8168.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. C. Wesselkamper, S. A. McDowell, M. Medvedovic, T. P. Dalton, H. S. Deshmukh, M. A. Sartor, L. M. Case, L. N. Henning, M. T. Borchers, C. R. Tomlinson, et al.
The Role of Metallothionein in the Pathogenesis of Acute Lung Injury
Am. J. Respir. Cell Mol. Biol.,
January 1, 2006;
34(1):
73 - 82.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. H. Kim, H. Y. Kim, S. Kim, J.-H. Chung, W. S. Park, and D. H. Chung
Natural Killer T (NKT) Cells Attenuate Bleomycin-Induced Pulmonary Fibrosis by Producing Interferon-{gamma}
Am. J. Pathol.,
November 1, 2005;
167(5):
1231 - 1241.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Mestas, M. D. Burdick, K. Reckamp, A. Pantuck, R. A. Figlin, and R. M. Strieter
The Role of CXCR2/CXCR2 Ligand Biological Axis in Renal Cell Carcinoma
J. Immunol.,
October 15, 2005;
175(8):
5351 - 5357.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J. Phillips, J. Mestas, M. Gharaee-Kermani, M. D. Burdick, A. Sica, J. A. Belperio, M. P. Keane, and R. M. Strieter
Epidermal Growth Factor and Hypoxia-induced Expression of CXC Chemokine Receptor 4 on Non-small Cell Lung Cancer Cells Is Regulated by the Phosphatidylinositol 3-Kinase/PTEN/AKT/Mammalian Target of Rapamycin Signaling Pathway and Activation of Hypoxia Inducible Factor-1{alpha}
J. Biol. Chem.,
June 10, 2005;
280(23):
22473 - 22481.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Arora, Y. Hernandez, J. R. Erb-Downward, R. A. McDonald, G. B. Toews, and G. B. Huffnagle
Role of IFN-{gamma} in Regulating T2 Immunity and the Development of Alternatively Activated Macrophages during Allergic Bronchopulmonary Mycosis
J. Immunol.,
May 15, 2005;
174(10):
6346 - 6356.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. B. Moore, J. E. Kolodsick, V. J. Thannickal, K. Cooke, T. A. Moore, C. Hogaboam, C. A. Wilke, and G. B. Toews
CCR2-Mediated Recruitment of Fibrocytes to the Alveolar Space after Fibrotic Injury
Am. J. Pathol.,
March 1, 2005;
166(3):
675 - 684.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. Chen, L. Rabach, P. Noble, T. Zheng, C. G. Lee, R. J. Homer, and J. A. Elias
IL-11 Receptor {alpha} in the Pathogenesis of IL-13-Induced Inflammation and Remodeling
J. Immunol.,
February 15, 2005;
174(4):
2305 - 2313.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Oda, P. B. Canelos, D. M. Essayan, B. A. Plunkett, A. C. Myers, and S.-K. Huang
Interleukin-17F Induces Pulmonary Neutrophilia and Amplifies Antigen-induced Allergic Response
Am. J. Respir. Crit. Care Med.,
January 1, 2005;
171(1):
12 - 18.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Cavarra, F. Carraro, S. Fineschi, A. Naldini, B. Bartalesi, A. Pucci, and G. Lungarella
Early response to bleomycin is characterized by different cytokine and cytokine receptor profiles in lungs
Am J Physiol Lung Cell Mol Physiol,
December 1, 2004;
287(6):
L1186 - L1192.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Belperio, M. Dy, L. Murray, M. D. Burdick, Y. Y. Xue, R. M. Strieter, and M. P. Keane
The Role of the Th2 CC Chemokine Ligand CCL17 in Pulmonary Fibrosis
J. Immunol.,
October 1, 2004;
173(7):
4692 - 4698.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. G. Lee, S. J. Cho, M. J. Kang, S. P. Chapoval, P. J. Lee, P. W. Noble, T. Yehualaeshet, B. Lu, R. A. Flavell, J. Milbrandt, et al.
Early Growth Response Gene 1-mediated Apoptosis Is Essential for Transforming Growth Factor {beta}1-induced Pulmonary Fibrosis
J. Exp. Med.,
August 2, 2004;
200(3):
377 - 389.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Ryzhov, A. E. Goldstein, A. Matafonov, D. Zeng, I. Biaggioni, and I. Feoktistov
Adenosine-Activated Mast Cells Induce IgE Synthesis by B Lymphocytes: An A2B-Mediated Process Involving Th2 Cytokines IL-4 and IL-13 with Implications for Asthma
J. Immunol.,
June 15, 2004;
172(12):
7726 - 7733.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. E. Kolodsick, G. B. Toews, C. Jakubzick, C. Hogaboam, T. A. Moore, A. McKenzie, C. A. Wilke, C. J. Chrisman, and B. B. Moore
Protection from Fluorescein Isothiocyanate-Induced Fibrosis in IL-13-Deficient, but Not IL-4-Deficient, Mice Results from Impaired Collagen Synthesis by Fibroblasts
J. Immunol.,
April 1, 2004;
172(7):
4068 - 4076.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. P. Keane, J. A. Belperio, Y. Y. Xue, M. D. Burdick, and R. M. Strieter
Depletion of CXCR2 Inhibits Tumor Growth and Angiogenesis in a Murine Model of Lung Cancer
J. Immunol.,
March 1, 2004;
172(5):
2853 - 2860.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Ma, Z. Zhu, R. J. Homer, C. Gerard, R. Strieter, and J. A. Elias
The C10/CCL6 Chemokine and CCR1 Play Critical Roles in the Pathogenesis of IL-13-Induced Inflammation and Remodeling
J. Immunol.,
February 1, 2004;
172(3):
1872 - 1881.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Kaminski, J. A. Belperio, P. B. Bitterman, L. Chen, S. W. Chensue, A. M.K. Choi, S. Dacic, J. H. Dauber, R. M. du Bois, J. J. Enghild, et al.
Idiopathic Pulmonary Fibrosis
Am. J. Respir. Cell Mol. Biol.,
September 1, 2003;
29(3):
S1 - 105.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W A Dik, R J McAnulty, M A Versnel, B A E Naber, L J I Zimmermann, G J Laurent, and S E Mutsaers
Short course dexamethasone treatment following injury inhibits bleomycin induced fibrosis in rats
Thorax,
September 1, 2003;
58(9):
765 - 771.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Jakubzick, E. S. Choi, B. H. Joshi, M. P. Keane, S. L. Kunkel, R. K. Puri, and C. M. Hogaboam
Therapeutic Attenuation of Pulmonary Fibrosis Via Targeting of IL-4- and IL-13-Responsive Cells
J. Immunol.,
September 1, 2003;
171(5):
2684 - 2693.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. N.J. McKenzie and P. G. Fallon
Decoy Receptors in the Regulation of T Helper Cell Type 2 Responses
J. Exp. Med.,
March 17, 2003;
197(6):
675 - 679.
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 American Thoracic Society.
|
|
|